22nd Century Group Announces Study From France's ANSES Identifies Its Technology Supportive In Nicotine Reduction In Combustible Tobacco Products

22nd Century Group Calls On HHS And FDA Secretary Kennedy, Acting FDA Commissioner Diamantas And CTP Director Koplow To Enact And Implement The Reduced Nicotine Content Standard

22nd Century Group Calls on HHS Secretary Kennedy, Acting FDA Commissioner Diamantas and CTP Director Koplow to Enact and Implement the Reduced Nicotine Content StandardAdministration’s Reported Move to Accelerate Vape

Why GlucoTrack Shares Are Trading Higher By Around 118%; Here Are 20 Stocks Moving Premarket

GlucoTrack surged 117.7% premarket after Lokahi Therapeutics signed its first external partnership; other stocks saw notable gains and losses.

22nd Century Group shares are trading higher following reports suggesting that U.S. regulators plan to speed authorizations of vapes and tobacco pouches.